JPMorgan Chase & Co’s Cocrystal Pharma COCP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-104
| Closed | -$148 | – | 6237 |
|
|
2025
Q1 | $148 | Sell |
104
-155
| -60% | -$221 | ﹤0.01% | 5957 |
|
|
2024
Q4 | $523 | Sell |
259
-152
| -37% | -$307 | ﹤0.01% | 5742 |
|
|
2024
Q3 | $723 | Sell |
411
-17
| -4% | -$30 | ﹤0.01% | 5691 |
|
|
2024
Q2 | $997 | Sell |
428
-115
| -21% | -$268 | ﹤0.01% | 5597 |
|
|
2024
Q1 | $776 | Sell |
543
-1,653
| -75% | -$2.36K | ﹤0.01% | 5655 |
|
|
2023
Q4 | $3.73K | Buy |
2,196
+452
| +26% | +$768 | ﹤0.01% | 5583 |
|
|
2023
Q3 | $3.26K | Buy |
1,744
+1,291
| +285% | +$2.41K | ﹤0.01% | 5508 |
|
|
2023
Q2 | $1.08K | Buy |
453
+202
| +80% | +$483 | ﹤0.01% | 5539 |
|
|
2023
Q1 | $0 | Sell |
251
-9
| -3% | – | ﹤0.01% | 5834 |
|
|
2022
Q4 | $1K | Sell |
260
-73
| -22% | -$281 | ﹤0.01% | 5430 |
|
|
2022
Q3 | $1K | Sell |
333
-356
| -52% | -$1.07K | ﹤0.01% | 5387 |
|
|
2022
Q2 | $3K | Sell |
689
-166
| -19% | -$723 | ﹤0.01% | 5375 |
|
|
2022
Q1 | $6K | Sell |
855
-4,142
| -83% | -$29.1K | ﹤0.01% | 5461 |
|
|
2021
Q4 | $39K | Buy |
4,997
+4,902
| +5,160% | +$38.3K | ﹤0.01% | 5149 |
|
|
2021
Q3 | $1K | Buy |
+95
| New | +$1K | ﹤0.01% | 5428 |
|
|
2021
Q2 | – | Sell |
-117
| Closed | -$2K | – | 5495 |
|
|
2021
Q1 | $2K | Buy |
+117
| New | +$2K | ﹤0.01% | 5153 |
|